India develops powerful, homegrown antibiotic to tackle multi-drug-resistant bacteria
Wockhardt, a leading Indian pharmaceutical company has achieved a major breakthrough through the development of Zaynich as a new antibiotic. The new drug targets multi-drug-resistant (MDR) Gram-negative bacteria which show resistance to current antibiotic treatments. Zaynich uses zidebactam and cefepime as its active components, to deliver a strong new treatment for dangerous bacterial infections from…